These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Leflunomide. Cohen SB, Iqbal I. Int J Clin Pract; 2003 Mar; 57(2):115-20. PubMed ID: 12661795 [Abstract] [Full Text] [Related]
3. Is there a place for leflunomide in the treatment of rheumatoid arthritis? Breedveld FC. Lancet; 2001 Oct 13; 358(9289):1198-200. PubMed ID: 11675052 [No Abstract] [Full Text] [Related]
4. Acute hepatitis associated to leflunomide in a patient with rheumatoid arthritis. Chávez-López MA, Ramírez-González A, Martínez-Guevara MA. Gastroenterol Hepatol; 2007 Oct 13; 30(7):430. PubMed ID: 17692207 [No Abstract] [Full Text] [Related]
5. Leflunomide for active rheumatoid arthritis. Ferraccioli GF, De Vita S. Lancet; 1999 May 29; 353(9167):1883; author reply 1883-4. PubMed ID: 10359440 [No Abstract] [Full Text] [Related]
6. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis. Bartlett RR, Brendel S, Zielinski T, Schorlemmer HU. Transplant Proc; 1996 Dec 29; 28(6):3074-8. PubMed ID: 8962190 [No Abstract] [Full Text] [Related]
7. Efficacy and safety of leflunomide in active rheumatoid arthritis. Smolen JS, Emery P. Rheumatology (Oxford); 2000 Jun 29; 39 Suppl 1():48-56. PubMed ID: 11001380 [Abstract] [Full Text] [Related]
8. Leflunomide for rheumatoid arthritis. Drug Ther Bull; 2000 Jul 29; 38(7):52-4. PubMed ID: 11027115 [Abstract] [Full Text] [Related]
9. Leflunomide in treatment of rheumatoid arthritis. McCarey DW, Capell HA, Madhok R. Lancet; 2002 Mar 30; 359(9312):1158. PubMed ID: 11943298 [No Abstract] [Full Text] [Related]
10. Leflunomide-induced aseptic meningitis. Cohen JD, Jorgensen C, Sany J. Joint Bone Spine; 2004 May 30; 71(3):243-5. PubMed ID: 15182800 [Abstract] [Full Text] [Related]
11. [Treatment with leflunomide in rheumatoid arthritis]. Krüger K, Bolten W. Z Rheumatol; 2005 Mar 30; 64(2):96-101. PubMed ID: 15793675 [No Abstract] [Full Text] [Related]
12. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases. Herrmann ML, Schleyerbach R, Kirschbaum BJ. Immunopharmacology; 2000 May 30; 47(2-3):273-89. PubMed ID: 10878294 [Abstract] [Full Text] [Related]
13. [Leflunomide-induced toxic epidermal necrolysis]. El Aïdli S, Salouage I, Kastalli S, Srairi S, Daghfous R, Loueslati MH, Belkahia C. Therapie; 2008 May 30; 63(2):157-8. PubMed ID: 18677817 [No Abstract] [Full Text] [Related]
14. Vasculitis associated with the use of leflunomide. Macdonald J, Zhong T, Lazarescu A, Gan BS, Harth M. J Rheumatol; 2004 Oct 30; 31(10):2076-8. PubMed ID: 15468379 [Abstract] [Full Text] [Related]
15. Leflunomide for active rheumatoid arthritis. Bruyn GA, Griep EN, Korff KJ. Lancet; 1999 May 29; 353(9167):1883; author reply 1883-4. PubMed ID: 10359439 [No Abstract] [Full Text] [Related]
16. Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis. Mroczkowski PJ, Weinblatt ME, Kremer JM. Clin Exp Rheumatol; 1999 May 29; 17(6 Suppl 18):S66-8. PubMed ID: 10589360 [Abstract] [Full Text] [Related]
17. [Experience in long-term therapy of active rheumatoid arthritis with leflunomide]. Chichasova NV, Igolkina EV, Brodetskaia KA, Imametdinova GR. Ter Arkh; 2005 May 29; 77(5):33-8. PubMed ID: 15989000 [Abstract] [Full Text] [Related]
18. [Lichenoid drug reaction to leflunomide]. Canonne-Courivaud D, Carpentier O, Dejobert Y, Hachulla E, Delaporte E. Ann Dermatol Venereol; 2003 Apr 29; 130(4):435-7. PubMed ID: 12843855 [Abstract] [Full Text] [Related]
19. Leflunomide: a new DMARD for rheumatoid arthritis. Emery P. Hosp Med; 2000 May 29; 61(5):344-7. PubMed ID: 10953742 [Abstract] [Full Text] [Related]
20. Leflunomide: a novel DMARD for the treatment of rheumatoid arthritis. Alldred A, Emery P. Expert Opin Pharmacother; 2001 Jan 29; 2(1):125-37. PubMed ID: 11336574 [Abstract] [Full Text] [Related] Page: [Next] [New Search]